During the rather hostile takeover engineered by Valeant Pharmaceuticals to acquire Allergan, charges were made by Allergan officials that Valeant was “a house of cards,” however no context was provided. A research report from Citron Research today offers context. In a report that is sending Valeant's stock tumbling, Citron claims Valeant is an Enron-like fraud. They offer as proof hidden corporate connections and undocumented demands for what appear as kickback payments from pharmacies that sell drugs to consumers.
Valeant-controlled Phildor RX sued by R&O Pharmacy over undocumented rebate payments
The Citron research piece highlights to investors to Philidor RX Services, a Hatboro, PA pharmaceutical distributor, and R&O Pharmacy, a small California chain of...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
